Yanchik Connealy Pamela
- SEC CIK
- 0001796310
No open-market purchases or sales filed in the past year.
Current role at each company
- OBIO Orchestra BioMed Holdings, Inc.Directoras of Jun 25, 2026
- PYXS Pyxis Oncology, Inc.CFO & COOas of Apr 2, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Yanchik Connealy Pamela as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PYXS Pyxis Oncology, Inc.
CFO & COO5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 27, 2024 (view filing) | Nov 26 | 1 day | Yanchik Connealy PamelaCFO & COO | PPurchase | +88.8K | $1.96 | +$174.4K | +8.0%1.20M after | 2 lots |
| Sep 28, 2023 (view filing) | Sep 28 | Same day | Yanchik Connealy PamelaCFO and COO | PPurchase | +8.00K | $1.87 | +$15.0K | +1.0%818.5K after | |
| Sep 27, 2023 (view filing) | Sep 27 | Same day | Yanchik Connealy PamelaCFO and COO | PPurchase | +6.43K | $1.85 | +$11.9K | +0.8%810.5K after | |
| Sep 25, 2023 (view filing) | Sep 25 | Same day | Yanchik Connealy PamelaCFO and COO | PPurchase | +12.0K | $1.67 | +$20.0K | +1.5%804.1K after | |
| Sep 22, 2023 (view filing) | Sep 22 | Same day | Yanchik Connealy PamelaCFO and COO | PPurchase | +5.00K | $1.74 | +$8.70K | +0.6%792.1K after |